Valuation: StimCell Energetics Inc.

Market Cap 6.34M 5.5M 5.15M 4.7M 8.84M 605M 8.98M 60.68M 23.69M 303M 23.81M 23.3M 1.01B P/E 2026 *
-7.5x
P/E 2027 * -15x
Enterprise Value 7.14M 6.19M 5.8M 5.29M 9.96M 682M 10.12M 68.34M 26.68M 341M 26.81M 26.23M 1.14B EV / Sales 2026 *
-
EV / Sales 2027 * -
Free-Float
28.33%
Yield 2026 *
-
Yield 2027 * -
1 week+7.91%
Current month+6.76%
1 month+8.70%
3 months+1.01%
6 months-27.67%
Current year-25.00%
1 week 0.3
Extreme 0.3
0.35
1 month 0.27
Extreme 0.2655
0.35
Current year 0.27
Extreme 0.2655
0.48
1 year 0.25
Extreme 0.2501
0.48
3 years 0
Extreme 0.0015
13.97
5 years 0
Extreme 1.4E-5
13.97
10 years 0
Extreme 1.4E-5
25.35
Manager TitleAgeSince
Chief Executive Officer 56 12/12/2023
Director of Finance/CFO 48 24/11/2014
Director TitleAgeSince
Chairman 78 26/02/2024
Director/Board Member 62 08/06/2020
Director/Board Member 56 12/12/2023
Date Insider Type Main position Quantity % Market Cap.
12/18/25 A Sell

Director

16,667 0.0807%
3/17/25 A Tax

Director

60,841,472 307.0278%
2/25/25 A Buy 15,000 0.0757%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+7.91%+11.11%+1.52% 6.34M
+1.17%+1.09%+4.03%+15.90% 48.72B
-0.94%+2.92%+464.40%+578.60% 43.99B
-1.04%+7.47%+15.25%+73.62% 40.82B
-0.95%+3.17%+26.06%+8.94% 39.79B
0.00%+6.15%+23.03%+48.00% 32.7B
-1.77%+0.23%+25.29%+120.75% 16.66B
-3.25%-1.07% - - 16.84B
+0.72%+0.31%+4.94%+21.57% 13.95B
-0.43%+6.77%+82.89%+30.69% 13.58B
Average -0.64%+4.13%+73.00%+99.96% 26.7B
Weighted average by Cap. -0.52%+3.66%+98.54%+135.45%

Financials

2026 *2027 *
Net sales - -
Net income -792M -687M -644M -587M -1.1B -75.63B -1.12B -7.58B -2.96B -37.86B -2.97B -2.91B -126B -510M -442M -414M -378M -711M -48.67B -722M -4.88B -1.9B -24.37B -1.91B -1.87B -81.28B
Net Debt 800K 693K 650K 593K 1.12M 76.35M 1.13M 7.65M 2.99M 38.22M 3M 2.94M 127M 800K 693K 650K 593K 1.12M 76.35M 1.13M 7.65M 2.99M 38.22M 3M 2.94M 127M
Logo StimCell Energetics Inc.
StimCell Energetics Inc. is a biotech company, which is focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness and alleviate health complications including, but not limited to aging, insulin sensitivity, high blood pressure, neuropathy and kidney function. The Company's main focus is on continued research and development of its eBalance Technology and its eBalance Home System. eBalance is a non-invasive, fully automated microcurrent electrotherapy system administering pre-programmed algorithms through the epidermis at the touch of a button to help you gain optimal wellness and reduce pain. Its eBalance represents a monumental stride in the realm of medical technology designed to rejuvenate and re-energize the human body at a cellular level. The operation of eBalance is an intricate process of precision engineering and human biology.
Employees
1
Date Price Change Volume
12/08/26 $0.3000 0.00% 3,470
11/08/26 $0.3000 -13.79% 10,030
07/08/26 $0.3480 +25.18% 1,000

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STME Stock